DocGo Inc. (NASDAQ:DCGO) Receives Average Rating of “Buy” from Brokerages

DocGo Inc. (NASDAQ:DCGO) has been assigned an average rating of “Buy” from the five ratings firms that are currently covering the firm, Marketbeat reports. Five equities research analysts have rated the stock with a buy recommendation. The average 1 year target price among analysts that have updated their coverage on the stock in the last year is $6.10.

A number of research analysts recently issued reports on DCGO shares. Needham & Company LLC reissued a “buy” rating and issued a $7.00 price objective on shares of DocGo in a research note on Thursday, August 8th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $5.00 price target on shares of DocGo in a research note on Friday.

Institutional Investors Weigh In On DocGo

A number of hedge funds and other institutional investors have recently bought and sold shares of the company. Isthmus Partners LLC raised its position in DocGo by 32.4% in the second quarter. Isthmus Partners LLC now owns 799,296 shares of the company’s stock valued at $25,000 after purchasing an additional 195,428 shares during the last quarter. nVerses Capital LLC increased its stake in shares of DocGo by 151.5% in the second quarter. nVerses Capital LLC now owns 8,300 shares of the company’s stock valued at $26,000 after buying an additional 5,000 shares during the period. Gladius Capital Management LP bought a new position in DocGo in the 2nd quarter valued at approximately $34,000. Nisa Investment Advisors LLC boosted its position in DocGo by 693.2% during the 2nd quarter. Nisa Investment Advisors LLC now owns 12,089 shares of the company’s stock worth $37,000 after buying an additional 10,565 shares during the period. Finally, SG Americas Securities LLC bought a new stake in DocGo during the 2nd quarter worth approximately $60,000. Institutional investors own 56.44% of the company’s stock.

DocGo Stock Performance

DCGO opened at $3.48 on Monday. The firm has a market cap of $353.45 million, a P/E ratio of 17.40, a price-to-earnings-growth ratio of 3.02 and a beta of 0.92. The business’s fifty day moving average is $3.49 and its 200-day moving average is $3.41. DocGo has a 52-week low of $2.75 and a 52-week high of $6.90.

DocGo (NASDAQ:DCGO) last announced its quarterly earnings data on Wednesday, August 7th. The company reported $0.06 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.07 by ($0.01). The firm had revenue of $164.95 million for the quarter, compared to analyst estimates of $166.61 million. DocGo had a return on equity of 8.90% and a net margin of 3.97%. On average, research analysts predict that DocGo will post 0.23 earnings per share for the current fiscal year.

DocGo Company Profile

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.